%0 Journal Article
%K Monoclonal antibodies
%K new approach methodologies
%K Non-human primate toxicity
%K Nonclinical safety assessment
%K Regulatory toxicity
%K Repeat-dose toxicity studies
%B Regulatory Toxicology and Pharmacology
%D 2026
%P 106124
%R 10.1016/j.yrtph.2026.106124
%T FDA CDER analysis of non-human primate (NHP) data in monoclonal antibody (mAb) development to support the streamlining of nonclinical safety studies
%U https://www.sciencedirect.com/science/article/pii/S0273230026000978
%V 170
%8 2026-09-01